MX290450B - Uso de un copolimero de (met) acrilato anionico, parcialmente neutralizado, como un revestimiento para la produccion de una forma farmaceutica que libera sustancia activa con valores ph reducidos. - Google Patents

Uso de un copolimero de (met) acrilato anionico, parcialmente neutralizado, como un revestimiento para la produccion de una forma farmaceutica que libera sustancia activa con valores ph reducidos.

Info

Publication number
MX290450B
MX290450B MX2007015954A MX2007015954A MX290450B MX 290450 B MX290450 B MX 290450B MX 2007015954 A MX2007015954 A MX 2007015954A MX 2007015954 A MX2007015954 A MX 2007015954A MX 290450 B MX290450 B MX 290450B
Authority
MX
Mexico
Prior art keywords
copolimero
met
values
production
cover
Prior art date
Application number
MX2007015954A
Other languages
English (en)
Other versions
MX2007015954A (es
Inventor
Hans-Ulrich Petereit
Manfred Assmus
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2007015954A publication Critical patent/MX2007015954A/es
Publication of MX290450B publication Critical patent/MX290450B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2007015954A 2005-07-12 2006-04-05 Uso de un copolimero de (met) acrilato anionico, parcialmente neutralizado, como un revestimiento para la produccion de una forma farmaceutica que libera sustancia activa con valores ph reducidos. MX290450B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005032806A DE102005032806A1 (de) 2005-07-12 2005-07-12 Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
PCT/EP2006/003115 WO2007006353A2 (de) 2005-07-12 2006-04-05 Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten

Publications (2)

Publication Number Publication Date
MX2007015954A MX2007015954A (es) 2008-10-27
MX290450B true MX290450B (es) 2011-09-23

Family

ID=37507688

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007015954A MX290450B (es) 2005-07-12 2006-04-05 Uso de un copolimero de (met) acrilato anionico, parcialmente neutralizado, como un revestimiento para la produccion de una forma farmaceutica que libera sustancia activa con valores ph reducidos.

Country Status (15)

Country Link
US (1) US7932258B2 (es)
EP (1) EP1906939B1 (es)
JP (1) JP5193036B2 (es)
KR (1) KR101325901B1 (es)
CN (1) CN101193627A (es)
BR (1) BRPI0612878A2 (es)
CA (1) CA2609439C (es)
DE (1) DE102005032806A1 (es)
ES (1) ES2588173T3 (es)
HU (1) HUE028344T2 (es)
IL (1) IL186553A0 (es)
MX (1) MX290450B (es)
PL (1) PL1906939T3 (es)
SI (1) SI1906939T1 (es)
WO (1) WO2007006353A2 (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
JP5167345B2 (ja) * 2007-05-07 2013-03-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤を加速放出する腸溶コーティングを含む固体剤形
RU2010119041A (ru) * 2007-10-12 2011-11-20 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи
WO2009113703A2 (en) 2008-03-11 2009-09-17 Takeda Pharmaceutical Company Limited Orally-disintegrating solid preparation
DE102010003547A1 (de) * 2009-04-02 2010-10-14 Innotere Gmbh Bioaktiver Knochenzement und Verfahren zu seiner Herstellung
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
CA2766172C (en) 2009-07-22 2017-09-12 Lutz Barnscheid Oxidation-stabilized tamper-resistant dosage form
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
EP2736497B1 (en) 2011-07-29 2017-08-23 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
US10799460B2 (en) 2011-09-07 2020-10-13 Roland SAUR-BROSCH Formulation for the controlled release of one or several substances in the digestive tract of a mammal
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
JP6282261B2 (ja) * 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
ES2655622T3 (es) 2012-04-30 2018-02-20 Tillotts Pharma Ag Una formulación de fármaco de liberación retardada
CN102846386B (zh) * 2012-09-19 2015-02-25 四川大学 智能可控释放抗菌成分的牙种植体及制备方法
WO2014191397A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
KR102237356B1 (ko) * 2013-10-29 2021-04-08 틸로츠 파마 아게 지연 방출 약물 제형
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN106317426A (zh) * 2016-08-19 2017-01-11 湖州展望天明药业有限公司 一种可再分散的聚丙烯酸树脂粉末及其制备方法
EP3662895A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG A process for manufacturing reducing sugar-free 5-asa tablet cores
EP3662901A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Delayed release drug formulation comprising an outerlayer with an enzymaticyaaly degradable polymer, its composition and its method of manufacturing
EP3662902B1 (en) 2018-12-07 2024-07-31 Tillotts Pharma AG Colonic drug delivery formulation
EP3662900A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662898A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
WO2021115648A1 (en) 2019-12-11 2021-06-17 Evonik Operations Gmbh Dosage form comprising an alkaline agent and an enteric coating layer
JP2023505883A (ja) 2019-12-11 2023-02-13 エボニック オペレーションズ ゲーエムベーハー 病気の治療又は予防において使用するための剤形
KR20220113698A (ko) 2019-12-11 2022-08-16 에보닉 오퍼레이션스 게엠베하 질환을 치료 또는 예방하는데 사용하기 위한 투여 형태
AU2020413225A1 (en) 2019-12-27 2022-06-23 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
TW202140051A (zh) 2020-01-17 2021-11-01 美商艾弗洛生物科技股份有限公司 具有改善的崩散譜之固體劑型
EP4135670A1 (en) 2020-04-17 2023-02-22 Evelo Biosciences, Inc. Solid dosage forms with improved disintegration profiles
EP4213814A1 (en) 2020-09-18 2023-07-26 Evelo Biosciences, Inc. Solid dosage forms of bacteria
WO2022061123A1 (en) 2020-09-21 2022-03-24 Evelo Biosciences, Inc. Solid dosage forms with improved disintegration profiles
CN116648253A (zh) 2020-10-29 2023-08-25 伊夫罗生物科学公司 包含螺旋藻组分的组合物
WO2022125005A1 (en) * 2020-12-08 2022-06-16 Santa Farma Ilac Sanayii A. S. Stable sustained release compositions of acemetacine
US20240058271A1 (en) 2020-12-14 2024-02-22 Kevin Huynh Extracellular vesicle preparations
EP4267154A1 (en) 2020-12-22 2023-11-01 Evelo Biosciences, Inc. Compositions comprising animal hemoglobin
EP4284400A1 (en) 2021-01-26 2023-12-06 Evelo Biosciences, Inc. Prevotella extracellular vesicle preparations
EP4297762A1 (en) 2021-02-26 2024-01-03 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
TW202302125A (zh) 2021-03-05 2023-01-16 美商艾弗洛生物科技股份有限公司 固體劑型
TW202304415A (zh) 2021-04-08 2023-02-01 美商艾弗洛生物科技股份有限公司 含有細菌的藥物製劑
WO2022221183A1 (en) 2021-04-12 2022-10-20 Evelo Biosciences, Inc. Fournierella extracellular vesicle preparations
WO2022251166A2 (en) 2021-05-25 2022-12-01 Evelo Biosciences, Inc. Bacterial compositions comprising soy hemoglobin
WO2023049268A1 (en) 2021-09-24 2023-03-30 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
WO2023114300A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Fournierella massiliensis bacteria extracellular vesicle preparations
WO2023114296A2 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Extracellular vesicle preparations
WO2023114295A1 (en) 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Veillonella parvula bacteria extracellular vesicle preparations
WO2023146843A1 (en) 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023183396A1 (en) 2022-03-22 2023-09-28 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023200837A1 (en) 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023239728A1 (en) 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles
WO2024102226A1 (en) 2022-10-14 2024-05-16 Evelo Biosciences, Inc. Methods for assaying drug substances and drug products by using cell lines with nf-kb- inducible reporter genes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
DE19626045C2 (de) * 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
US6174548B1 (en) * 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
AU2161000A (en) * 1998-12-07 2000-06-26 Bristol-Myers Squibb Company Enteric coated pravastatin bead formulation
AU2002314306C1 (en) * 2001-05-30 2008-12-04 Euro-Celtique S.A. Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl
DE10208335A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
DE102005007059A1 (de) * 2005-02-15 2006-08-24 Röhm GmbH & Co. KG Teilneutralisiertes anionisches (Meth)acrylat-Copolymer
BRPI0621996B8 (pt) * 2006-08-18 2022-07-05 Evonik Roehm Gmbh preparação farmacêutica compreendendo um núcleo com um ingrediente ativo e com um ácido orgânico e/ou com o sal de um ácido orgânico, e um revestimento que envolve o núcleo e que compreende um ou mais copolímeros de (met)acrilato, e seu uso.

Also Published As

Publication number Publication date
CN101193627A (zh) 2008-06-04
EP1906939A2 (de) 2008-04-09
KR20080024200A (ko) 2008-03-17
PL1906939T3 (pl) 2016-12-30
SI1906939T1 (sl) 2016-10-28
CA2609439C (en) 2013-10-29
US20080200482A1 (en) 2008-08-21
IL186553A0 (en) 2008-01-20
WO2007006353A3 (de) 2007-04-12
US7932258B2 (en) 2011-04-26
WO2007006353A2 (de) 2007-01-18
KR101325901B1 (ko) 2013-11-07
EP1906939B1 (de) 2016-06-01
JP2009501163A (ja) 2009-01-15
ES2588173T3 (es) 2016-10-31
DE102005032806A1 (de) 2007-01-18
CA2609439A1 (en) 2007-01-18
HUE028344T2 (en) 2016-12-28
MX2007015954A (es) 2008-10-27
BRPI0612878A2 (pt) 2010-11-30
JP5193036B2 (ja) 2013-05-08

Similar Documents

Publication Publication Date Title
MX290450B (es) Uso de un copolimero de (met) acrilato anionico, parcialmente neutralizado, como un revestimiento para la produccion de una forma farmaceutica que libera sustancia activa con valores ph reducidos.
WO2006131721A3 (en) Topical ungual formulations
USD696338S1 (en) Type font
BRPI0923823A2 (pt) Agente de colaboração.
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
DK1907037T3 (da) Medikamentdispenser.
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0815773A2 (pt) composto, e, medicamento.
BRPI0815578A2 (pt) Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo.
BRPI0921365A2 (pt) cartucho, um dispensador de produtos farmacêuticos que contém o cartucho, bem como as aplicações do catucho e do dispensador de produtos farmacêuticos.
BRPI0811470A2 (pt) Paralelização de estruturas sequenciais usando transações.
NL1030571A1 (nl) Geurafgiftesysteem.
USD650833S1 (en) Typeface
BRPI0922066A2 (pt) processos para a fabricação de metilmercaptopropionaldeido e da metionina ou do hidroxianalogo da metionina, metilmercaptopropinaldeido,metionina ou hidroxianalogo da metionina, e, utilização da metionina ou do hidroxianalogo da metionina.
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
NL1032108A1 (nl) Geurafgiftesysteem.
BRPI0719706A2 (pt) Processo para a preparação do 1,3-propanodiol.
BRPI0912163A2 (pt) Composto químico, processo para a produção de um composto, compsição química, e, uso de um composto químico.
BRPI0919694A2 (pt) composto, composto farmacêutica, uso de um composto, e, método de tratamento de uma doença.
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0716049A2 (pt) dispersÕes de nanourÉias, contendo substÂncias ativas
DE602006007271D1 (de) Hochdruckkraftstoffsystem mit Druckverstärker
WO2010027590A3 (en) Solution microarrays and uses thereof
BRPI0821197A2 (pt) Composto, composição farmacêutica, uso de um composto, processo, e, intermediário.
CL2007002727A1 (es) Proceso de preparacion de anastrozol; y compuestos intermediarios.

Legal Events

Date Code Title Description
FG Grant or registration